Skip to main content
Log in

Arsenic revisited

potential in acute promyelocytic leukaemia?

  • Newsletter Article
  • Published:
Inpharma Weekly

Abstract

Arsenic has been used as a medicine for thousands of years. In the late 19th century it was administered as a treatment for syphilis. Early in this century, arsenic was commonly prescribed for certain types of leukemia; however, its use in hematological disorders died out in the 1930s with the advent of radiotherapy. At present, its only medical indication is for African sleeping sickness. But recent studies have revived interest in arsenicals as treatment for acute promyelocytic leukemia (APL), according to speakers at the Chemotherapy Foundation Symposium XVI [ New York City, US; Nov, 1998 ].

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Carlson, R. Arsenic revisited. Inpharma Wkly. 1174, 13–14 (1999). https://doi.org/10.2165/00128413-199911740-00023

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128413-199911740-00023

Keywords

Navigation